vs

Side-by-side financial comparison of Emerald Holding, Inc. (EEX) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

Emerald Holding, Inc. is the larger business by last-quarter revenue ($132.7M vs $83.1M, roughly 1.6× PROCEPT BioRobotics Corp). Emerald Holding, Inc. runs the higher net margin — -22.8% vs -38.1%, a 15.3% gap on every dollar of revenue. On growth, Emerald Holding, Inc. posted the faster year-over-year revenue change (24.3% vs 20.2%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -0.3%).

TVS Emerald Haven Realty Limited is an Indian real estate development company headquartered in Chennai, Tamil Nadu. A subsidiary of TVS Holdings, it specializes in sustainable residential communities and urban development projects.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

EEX vs PRCT — Head-to-Head

Bigger by revenue
EEX
EEX
1.6× larger
EEX
$132.7M
$83.1M
PRCT
Growing faster (revenue YoY)
EEX
EEX
+4.1% gap
EEX
24.3%
20.2%
PRCT
Higher net margin
EEX
EEX
15.3% more per $
EEX
-22.8%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-0.3%
EEX

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
EEX
EEX
PRCT
PRCT
Revenue
$132.7M
$83.1M
Net Profit
$-30.2M
$-31.6M
Gross Margin
64.9%
Operating Margin
-11.8%
-4.1%
Net Margin
-22.8%
-38.1%
Revenue YoY
24.3%
20.2%
Net Profit YoY
-692.2%
-27.9%
EPS (diluted)
$-0.15
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EEX
EEX
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$132.7M
$76.4M
Q3 25
$77.5M
$83.3M
Q2 25
$105.5M
$79.2M
Q1 25
$147.7M
$69.2M
Q4 24
$106.8M
$68.2M
Q3 24
$72.6M
$58.4M
Q2 24
$86.0M
$53.4M
Net Profit
EEX
EEX
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-30.2M
$-29.8M
Q3 25
$-14.4M
$-21.4M
Q2 25
$-1.4M
$-19.6M
Q1 25
$15.3M
$-24.7M
Q4 24
$5.1M
$-18.9M
Q3 24
$-11.1M
$-21.0M
Q2 24
$-2.8M
$-25.6M
Gross Margin
EEX
EEX
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
EEX
EEX
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-11.8%
-40.6%
Q3 25
-10.1%
-27.8%
Q2 25
9.7%
-28.0%
Q1 25
24.2%
-39.7%
Q4 24
19.5%
-28.9%
Q3 24
-6.5%
-38.4%
Q2 24
7.4%
-50.3%
Net Margin
EEX
EEX
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-22.8%
-39.1%
Q3 25
-18.6%
-25.7%
Q2 25
-1.3%
-24.7%
Q1 25
10.4%
-35.8%
Q4 24
4.8%
-27.6%
Q3 24
-15.3%
-35.9%
Q2 24
-3.3%
-48.0%
EPS (diluted)
EEX
EEX
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.15
$-0.54
Q3 25
$-0.07
$-0.38
Q2 25
$-0.01
$-0.35
Q1 25
$0.08
$-0.45
Q4 24
$0.01
$-0.34
Q3 24
$-0.05
$-0.40
Q2 24
$-0.03
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EEX
EEX
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$100.9M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$338.8M
$347.7M
Total Assets
$1.2B
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EEX
EEX
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$100.9M
$286.5M
Q3 25
$95.4M
$294.3M
Q2 25
$156.4M
$302.7M
Q1 25
$276.8M
$316.2M
Q4 24
$194.8M
$333.7M
Q3 24
$188.9M
$196.8M
Q2 24
$193.2M
$214.1M
Total Debt
EEX
EEX
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
EEX
EEX
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$338.8M
$365.9M
Q3 25
$369.5M
$380.3M
Q2 25
$389.4M
$385.8M
Q1 25
$392.1M
$389.2M
Q4 24
$385.9M
$402.2M
Q3 24
$391.1M
$241.2M
Q2 24
$407.6M
$251.8M
Total Assets
EEX
EEX
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$1.2B
$508.1M
Q3 25
$1.2B
$511.5M
Q2 25
$1.2B
$513.1M
Q1 25
$1.2B
$519.4M
Q4 24
$1.0B
$534.0M
Q3 24
$1.1B
$374.1M
Q2 24
$1.1B
$374.4M
Debt / Equity
EEX
EEX
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EEX
EEX
PRCT
PRCT
Operating Cash FlowLast quarter
$12.3M
Free Cash FlowOCF − Capex
$11.7M
FCF MarginFCF / Revenue
8.8%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$41.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EEX
EEX
PRCT
PRCT
Q1 26
Q4 25
$12.3M
$-10.3M
Q3 25
$1.8M
$-6.6M
Q2 25
$15.9M
$-15.0M
Q1 25
$12.6M
$-17.0M
Q4 24
$20.6M
$-32.4M
Q3 24
$9.1M
$-18.8M
Q2 24
$9.8M
$-15.7M
Free Cash Flow
EEX
EEX
PRCT
PRCT
Q1 26
Q4 25
$11.7M
$-12.2M
Q3 25
$1.5M
$-9.5M
Q2 25
$15.8M
$-17.8M
Q1 25
$12.4M
$-18.8M
Q4 24
$19.9M
$-33.6M
Q3 24
$9.0M
$-19.0M
Q2 24
$9.6M
$-16.8M
FCF Margin
EEX
EEX
PRCT
PRCT
Q1 26
Q4 25
8.8%
-15.9%
Q3 25
1.9%
-11.4%
Q2 25
15.0%
-22.5%
Q1 25
8.4%
-27.2%
Q4 24
18.6%
-49.2%
Q3 24
12.4%
-32.6%
Q2 24
11.2%
-31.4%
Capex Intensity
EEX
EEX
PRCT
PRCT
Q1 26
Q4 25
0.5%
2.4%
Q3 25
0.4%
3.4%
Q2 25
0.1%
3.5%
Q1 25
0.1%
2.7%
Q4 24
0.7%
1.7%
Q3 24
0.1%
0.4%
Q2 24
0.2%
2.0%
Cash Conversion
EEX
EEX
PRCT
PRCT
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
0.82×
Q4 24
4.04×
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EEX
EEX

Connections Segment$121.9M92%
Commerce Segment$5.5M4%
Content$5.3M4%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons